Research Interests
I have a robust foundation in obesity research, with 18 years dedicated to identifying and understanding metabolic phenotypes in primary human stem cells. My research program aims to understand how fetal exposures predispose infants to metabolic disease later in life. In pursuit of this goal, my lab pioneered the use of mesenchymal stem cells collected from umbilical cord tissue of newborn infants to investigate molecular and metabolic phenotypes predictive of future disease risk. Such tools have allowed us to identify children most at risk for excess adiposity in childhood with greater precision than other common measures collected at birth. As we move toward precision approaches for obesity prevention, infant stem cells will help to identify gestational exposures most impactful, and their modifiability through pregnancy interventions, thereby informing evidence-based prenatal clinical care.